FP&A Principal Analyst, Drug Substance Finance
Moderna
About this role
The Principal Analyst, Drug Substance Finance is an individual contributor based in Warsaw supporting financial oversight for Moderna’s internal Drug Substance manufacturing footprint (~$0.6B in spend). The role partners with Global Drug Substance Operations and the international business services hub to advance digital finance capabilities and strategic financial clarity across manufacturing sites. It contributes to Moderna’s mission to develop mRNA medicines by informing high-impact financial decisions.
Skills
Qualifications
About Moderna
modernatx.comModerna is a biotechnology company that is pioneering the use of mRNA technology to develop transformative medicines and vaccines. It gained global prominence for its COVID-19 vaccine, which showcased the potential of mRNA in rapidly addressing public health emergencies. The company is focused on creating innovative therapies to treat a range of diseases, advancing its product pipeline, and exploring new career opportunities in the biotech field. With a commitment to changing the landscape of medicine, Moderna is at the forefront of scientific research and development.
Recent company news
Moderna | History, Innovation, Challenges, & Facts | Britannica Money
5 days ago
An Erratic FDA Is a Threat to Innovation
5 hours ago
Moderna, Inc. $MRNA Position Increased by Theleme Partners LLP
2 hours ago
Moderna operates through several specialized therapeutic “pillars”:
6 hours ago
March 10 Business Watch: Syngenta ends paraquat production; Moderna settles lipid patent case
1 day ago
About Moderna
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Moderna.
Salary
$156k – $208k
per year